1.
Can the exacerbated synthesis of inflammatory markers in COVID-19 impair the response to treatments in patients with coronavirus?. RSD [Internet]. 2022 Aug. 24 [cited 2025 Dec. 5];11(11):e337111133562. Available from: https://rsdjournal.org/rsd/article/view/33562